Diabetes Management Devices Market

Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major factors contributing to the disease include obesity, urbanization, sedentary lifestyle, smoking, an elevated level of cholesterols, and hypertension. Vendors in this market are offering high-end insulin delivery systems (less invasive, sleek, pocket-sized, and portable devices) and continuous glucose monitoring systems, which are highly efficient and have user-friendly features.

Diabetes Management Devices Market contains market size and forecasts of Diabetes Management Devices in Global, including the following market information:

Global Diabetes Management Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Diabetes Management Devices market was valued at 41190 million in 2021 and is projected to reach US$ 64850 million by 2028, at a CAGR of 6.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Blood Glucose Monitoring Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetes Management Devices include Abbott Laboratories, Dexcom, Roche, Lifescan, Medtronic, Terumo, B. Braun Melsungen, BD and Ascensia (Bayer), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Diabetes Management Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetes Management Devices Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Diabetes Management Devices Market Segment Percentages, by Type, 2021 (%)

Blood Glucose Monitoring Device

Insulin Delivery Systems

Global Diabetes Management Devices Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Diabetes Management Devices Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Others

Global Diabetes Management Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Diabetes Management Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Diabetes Management Devices revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Diabetes Management Devices revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott Laboratories

Dexcom

Roche

Lifescan

Medtronic

Terumo

B. Braun Melsungen

BD

Ascensia (Bayer)

Senseonics Holdings

Johnson & Johnson

Eli Lilly

Novo Nordisk

Sanofi

Ypsomed Holding

GlySens Incorporated

Meiqi Medical Equipment

San Meditech

All Medicus